1. Home
  2. DIT vs ENTX Comparison

DIT vs ENTX Comparison

Compare DIT & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

HOLD

Current Price

$83.26

Market Cap

87.2M

ML Signal

HOLD

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.23

Market Cap

62.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIT
ENTX
Founded
1981
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
87.2M
62.6M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
DIT
ENTX
Price
$83.26
$1.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
546.0
100.4K
Earning Date
04-20-2026
05-14-2026
Dividend Yield
0.74%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
$1,392,388,157.00
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$17.86
Revenue Growth
5.30
N/A
52 Week Low
$78.00
$0.91
52 Week High
$126.50
$3.22

Technical Indicators

Market Signals
Indicator
DIT
ENTX
Relative Strength Index (RSI) 39.11 49.67
Support Level $80.10 $1.17
Resistance Level $120.08 $1.37
Average True Range (ATR) 1.46 0.09
MACD -0.19 0.00
Stochastic Oscillator 34.16 48.21

Price Performance

Historical Comparison
DIT
ENTX

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: